GG + BS01™ + BR03™ + BL03

Blend
Blend
On this page

Neurology

Chronic fatigue / Myalgic encephalomyelitis

Functionality

Improves sleep and cognitive symptoms in patients with ME/CFS

Anti-inflammatory activity

Supports healthy immunity

Dosage / Clinical Study

1) GG 25 billion CFU + BS01 15 billion CFU + BR03 5 billion CFU + BL03 5 billion CFU

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
Clinical studies

1) Wallis A. et al. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. J Transl Med. 2018 Feb 6;16(1):24. doi: 10.1186/s12967-018-1392-z.

In vitro studies

a) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019;  7:214. Doi: 10.35248/2329-8901.19.7.214
b) Nicola S. et al. Interaction between probiotics and human immune cells: the prospective anti-inflammatory activity of Bifidobacterium breve BR03. AgroFOOD, 2010; 21(2):S44-47

Associations